Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Abercrombie & Fitch
ANF
$4.91B
| $3.76M | ﹤0.01% |
117,536
-48,218
| -29% | -$1.67M |
|
1377
CALL
ON Semiconductor
ON
$18.6B
| $3.76M | ﹤0.01% |
+60,000
| New | +$3.66M |
|
1378
The Bancorp
TBBK
$2.95B
| $3.75M | ﹤0.01% |
132,414
-12,924
| -9% | -$372K |
|
|
SHLX
1379
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $3.73M | ﹤0.01% |
262,518
+242,116
| +1,187% | +$3.24M |
|
1380
JetBlue
JBLU
$2.34B
| $3.73M | ﹤0.01% |
249,619
-224,999
| -47% | -$3.26M |
|
|
RWT
1381
Redwood Trust
RWT
$573M
| $3.71M | ﹤0.01% |
352,498
+188,614
| +115% | +$2.15M |
|
1382
Teva Pharmaceuticals
TEVA
$40.6B
| $3.71M | ﹤0.01% |
395,345
-750,574
| -65% | -$6.26M |
|
|
PGM
1383
DELISTED
iPath Series B Bloomberg Platinum Subindex Total ReturnSM ETN
PGM
| $3.71M | ﹤0.01% |
80,000
| – | – |
|
1384
Remitly
RELY
$5.46B
| $3.69M | ﹤0.01% |
+374,050
| New | +$4.45M |
|
1385
Fluor
FLR
$6.81B
| $3.69M | ﹤0.01% |
128,568
-69,860
| -35% | -$1.69M |
|
|
SEM
1386
DELISTED
Select Medical
SEM
| $3.68M | ﹤0.01% |
284,400
-99,295
| -26% | -$1.31M |
|
1387
TAL Education Group
TAL
$6.91B
| $3.67M | ﹤0.01% |
1,221,338
+468,883
| +62% | +$1.44M |
|
1388
Axcelis
ACLS
$4.2B
| $3.67M | ﹤0.01% |
48,629
-8,212
| -14% | -$561K |
|
1389
AeroVironment
AVAV
$8.66B
| $3.67M | ﹤0.01% |
38,955
-1,030
| -3% | -$71.3K |
|
1390
Design Therapeutics
DSGN
$862M
| $3.66M | ﹤0.01% |
+226,511
| New | +$3.47M |
|
|
JJN
1391
DELISTED
iPath Series B Bloomberg Nickel Subindex Total ReturnSM ETN
JJN
| $3.64M | ﹤0.01% |
85,000
| – | – |
|
1392
Sonos
SONO
$1.83B
| $3.64M | ﹤0.01% |
128,955
-235,918
| -65% | -$6.27M |
|
1393
Perrigo
PRGO
$1.74B
| $3.64M | ﹤0.01% |
94,677
+6,433
| +7% | +$245K |
|
1394
Cameco
CCJ
$40.8B
| $3.64M | ﹤0.01% |
125,045
-501,216
| -80% | -$11.8M |
|
1395
Diodes
DIOD
$4.55B
| $3.63M | ﹤0.01% |
41,762
-15,431
| -27% | -$1.41M |
|
1396
Northwest Bancshares
NWBI
$2.29B
| $3.63M | ﹤0.01% |
268,345
+108,109
| +67% | +$1.53M |
|
1397
GameStop
GME
$8.63B
| $3.62M | ﹤0.01% |
86,856
-137,684
| -61% | -$4.07M |
|
|
VBTX
1398
DELISTED
Veritex Holdings
VBTX
| $3.62M | ﹤0.01% |
94,710
-25,181
| -21% | -$1.01M |
|
|
CUTR
1399
DELISTED
Cutera, Inc.
CUTR
| $3.59M | ﹤0.01% |
52,022
-13,867
| -21% | -$561K |
|
1400
Adtran
ADTN
$611M
| $3.59M | ﹤0.01% |
194,525
+129,888
| +201% | +$2.57M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.